Revolution Medicines, Inc. (NASDAQ:RVMDW – Get Free Report)’s stock price rose 2.2% during mid-day trading on Wednesday . The company traded as high as $6.68 and last traded at $6.40. Approximately 57,743 shares changed hands during mid-day trading, a decline of 58% from the average daily volume of 138,515 shares. The stock had previously closed at $6.26.
Revolution Medicines Price Performance
The company has a 50-day moving average price of $5.20 and a 200 day moving average price of $2.90.
Revolution Medicines Company Profile
Revolution Medicines (NASDAQ:RVMDW) is a clinical-stage oncology company focused on discovering and developing small-molecule therapies that target the RAS signaling pathway. The company’s scientific approach centers on designing molecules that selectively inhibit mutant RAS proteins and key regulators of RAS-driven cancers, with the goal of addressing tumor types that have historically been resistant to targeted therapies.
Revolution Medicines has advanced multiple pipeline candidates into clinical trials, including RMC-4630, a selective SHP2 inhibitor, and RMC-6236, an oral pan-RAS inhibitor designed to block signaling from multiple RAS mutants.
See Also
- Five stocks we like better than Revolution Medicines
- Cheap Thrills: Why These 3 Entertainment Stocks Are Soaring
- CoreWeave Insider Sales Look Big, But Should Investors Worry?
- Critical Metals: Sizing Up This Tiny Rare-Earth Stock Making Big Moves
- Meta and Cloud Computing: Real Potential, or a Shot in the Dark?
Receive News & Ratings for Revolution Medicines Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revolution Medicines and related companies with MarketBeat.com's FREE daily email newsletter.
